RFU Receives NIH Grant for Groundbreaking Research on Calcium Channels in Neurological Disorders

Groundbreaking Research on Calcium Channels at Rosalind Franklin University

Rosalind Franklin University (RFU) in North Chicago embarks on a significant advancement in neuroscience with the recent announcement that Dr. Hongkyun Kim has secured a substantial five-year grant from the National Institutes of Health (NIH). The grant, totaling $1,911,417, will enable Dr. Kim, a dedicated professor in the Center for Cancer Cell Biology, Immunology, and Infection, to conduct pioneering research on the molecular and cellular regulation of CaV2 voltage-gated calcium channels. These channels are essential for synaptic transmission and play a critical role in neuronal communication, making them a focal point in understanding various neurological disorders.

Dr. Kim’s research aims to unravel the complexities surrounding the dysregulation of CaV2 channels, a phenomenon often associated with conditions such as epilepsy, migraines, and chronic pain. By employing genetic and genomic methods, Dr. Kim seeks to identify the molecular components that regulate the abundance of these calcium channels, utilizing C. elegans as a model organism for his studies. His innovative approach is expected to provide deeper insights into how these channels function and contribute to disease pathology, potentially leading to new therapeutic avenues for individuals suffering from neurological disorders.

Joseph DiMario, RFU's executive vice president for research, commends Dr. Kim for his extensive contributions to the field, noting that this NIH award not only recognizes his expertise but also underscores the university's commitment to enhancing the understanding of critical biological mechanisms. RFU, known for its focus on health and biomedical education, continues to foster research that aligns with its mission to improve wellness and train future health professionals. The institution's efforts in neuroscience and brain-related diseases reflect the legacy of its namesake, Dr. Rosalind Franklin, who exemplified a spirit of inquiry and innovation.

In addition to this significant research funding, RFU remains dedicated to its core mission of education and research. The university comprises several colleges, including the Chicago Medical School and the College of Pharmacy, which collectively contribute to its reputation as a leader in health sciences. With the support of grants like the one awarded to Dr. Kim, RFU continues to position itself at the forefront of biomedical research, working tirelessly to address pressing health challenges faced by society.

This latest development not only promises to advance scientific knowledge but also highlights the important role of academic institutions in driving research that can lead to impactful health solutions. As RFU progresses with Dr. Kim’s groundbreaking work, the potential for improved treatments for neurological disorders becomes increasingly tangible.